Cisplatin + Paclitaxel
From OncoWiki
Jump to navigationJump to search
Indication
Bladder cancer
- Paclitaxel 175 mg/m2 ivi (3h) d1
- Cisplatin 75 mg/m2 ivi (30 min) d1
- Repeat q3w
References
Cervical Cancer
Neoadjuvant chemotherapy
- Cisplatin 60 mg/m2 iv d1
- Paclitaxel (Taxol) 60 mg/m2 iv d1
- Every 10 days x 3 cycles
References
Chemotherapy for stage IVB (metastatic) cancer
- Cisplatin 50 mg/m2 iv d1
- Paclitaxel (Taxol) 135 mg/m2 iv d1
- Q3w
References
Endometrial Cancer
Chemotherapy for stage IVB (metastatic) cancer
- Cisplatin 75 mg/m2 iv d1
- Paclitaxel (Taxol) 175 mg/m2 iv d1
- Q3w
References
Esophageal Cancer
Chemotherapy for stage IV (metastatic) cancer
- Cisplatin 75 mg/m2 iv d2
- Paclitaxel (Taxol) 200 mg/m2 civi over 24hrs d1
- Q3w
- G-CSF support
References
Gastric Cancer
Chemotherapy for locally advanced unresectable and metastatic cancer
- Cisplatin 60 mg/m2 iv d1
- Paclitaxel (Taxol) 160 mg/m2 iv d1
- Q2w
References
Ovarian Epithelial Cancer
Adjuvant chemotherapy
- Cisplatin 75 mg/m2 iv over 30 min d1
- Paclitaxel (Taxol) 135-175 mg/m2 iv over 3 hrs d1
- Q3w x 6 cycles
References
Chemotherapy for recurrent or metastatic cancer
- Cisplatin 50 mg/m2 iv d1
- Paclitaxel (Taxol) 175 mg/m2 iv over 3 hrs d1
- Q3w
References
Lung Cancer Non Small Cell
Chemotherapy for stage IV (metastatic) cancer
- Paclitaxel (Taxol) 175 mg/m2 iv day 1
- Cisplatin 75 mg/m2 iv day 2
- Q3w